Price
$1.67
Increased by +5.70%
Dollar volume (20D)
560.89 K
ADR%
7.35
Earnings report date
Nov 7, 2024
Shares float
42.38 M
Shares short
3.29 M [7.77%]
Shares outstanding
65.47 M
Market cap
103.44 M
Beta
1.62
Price/earnings
N/A
20D range
1.38 1.85
50D range
1.38 1.94
200D range
1.08 3.79

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease.

The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies.

Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 8, 24 -0.17
Increased by +54.05%
-0.15
Decreased by -13.33%
May 9, 24 -0.29
Increased by +30.95%
-0.22
Decreased by -31.82%
Mar 21, 24 -0.40
Increased by 0.00%
-0.39
Decreased by -2.56%
Nov 9, 23 -0.40
Increased by +20.00%
-0.40
Aug 8, 23 -0.37
Increased by +26.00%
-0.41
Increased by +9.76%
May 11, 23 -0.42
Increased by +16.00%
-0.44
Increased by +4.55%
Mar 23, 23 -0.40
Increased by +42.86%
-0.51
Increased by +21.57%
Nov 10, 22 -0.50
Increased by +50.00%
-0.49
Decreased by -2.04%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 24 0.00
Decreased by N/A%
-11.04 M
Decreased by -57.36%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-8.47 M
Decreased by -19.38%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 302.00 K
Increased by +N/A%
-8.06 M
Decreased by -18.61%
Decreased by -2.67 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-7.82 M
Decreased by -3.78%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-7.01 M
Increased by +4.47%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-7.09 M
Decreased by -5.58%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by -100.00%
-6.80 M
Increased by +4.72%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by -100.00%
-7.54 M
Increased by +12.62%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY